{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:00:28Z","timestamp":1787007628364,"version":"build-2736575974"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Roche and conducted by Creativ-Ceutical","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Market Access & Health Policy"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1080\/20016689.2019.1626171","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T10:59:50Z","timestamp":1561373990000},"page":"1626171","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France"],"prefix":"10.3390","volume":"7","author":[{"given":"Emilie","family":"Clay","sequence":"first","affiliation":[{"name":"HEOR, Creativ-Ceutical, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cristeau","sequence":"additional","affiliation":[{"name":"HEOR, Creativ-Ceutical, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Chafaie","sequence":"additional","affiliation":[{"name":"National Market Access & Price, ROCHE SAS, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandrina","family":"Pinta","sequence":"additional","affiliation":[{"name":"National Market Access & Price, ROCHE SAS, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mazaleyrat","sequence":"additional","affiliation":[{"name":"National Market Access & Price, ROCHE SAS, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[{"name":"Pulmonology Department, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.1.9704130"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0894CI"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.148031"},{"issue":"55","key":"CIT0004","volume":"38","author":"Nunes H","year":"2011","journal-title":"Eur Respir J"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2388"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.03.015"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00001511"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00026-2015"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00005209"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"CIT0012","volume-title":"Nintedanib for treating idiopathic pulmonary fibrosis (review of TA379) -Committee papers [ID752]","author":"NICE","year":"2015"},{"key":"CIT0013","volume-title":"Avis d\u2019efficience - ESBRIET\u00ae 267 mg (pirf\u00e9nidone)","author":"Haute Autorit\u00e9 de Sant\u00e9 (HAS)","year":"2015"},{"key":"CIT0014","volume-title":"Choix m\u00e9thodologiques pour l\u2019\u00e9valuation \u00e9conomique \u00e0 la HAS 2011","author":"Haute Autorit\u00e9 de Sant\u00e9 (HAS)"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2013.10.010"},{"issue":"20","key":"CIT0016","volume":"19","author":"Loveman E","year":"2015","journal-title":"Nat Inst Health Res"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131813"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1790OC"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-015-0034-y"},{"key":"CIT0020","unstructured":"Institut National de la Statistique et des Etudes Economiques (INSEE). Bilan d\u00e9mographique 2013; 2013. Available from: https:\/\/www.insee.fr\/fr\/statistiques\/12809562014"},{"key":"CIT0021","volume-title":"Le rapport m\u00e9dical et scientifique de l\u2019Agence de la biom\u00e9decine 2014","author":"Agence de biom\u00e9decine","year":"2014"},{"key":"CIT0022","volume-title":"Prevalence of rare diseases: bibliographic data","author":"Orphanet","year":"2014"},{"key":"CIT0023","unstructured":"CNAMTS; ID. Eco-Sant\u00e9, 2014. Irdes, Drees, Cnamts. Available from: http:\/\/www.ecosante.fr\/index2.php?base=DEPA&langh=FRA&langs=FRA"},{"key":"CIT0024","unstructured":"Caisse Nationale d\u2019Assurance Maladie (CNAM). Co\u00fbt des ALD en 2009; 2009. Available from: https:\/\/www.ameli.fr\/l-assurance-maladie\/statistiques-et-publications\/donnees-statistiques\/affection-de-longue-duree-ald\/archives\/cout-des-ald-en-2009.php"},{"issue":"3","key":"CIT0025","first-page":"198","volume":"31","author":"Costabel U","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00008513"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00600-7"},{"key":"CIT0028","volume-title":"Pirfenidone for treating idiopathic pulmonary fibrosis (review of TA282) - Committee papers [ID837]","author":"NICE","year":"2016"},{"key":"CIT0029","first-page":"1","volume":"2018","author":"Porte F","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"23","key":"CIT0030","first-page":"S5","volume":"2017","author":"Fleetwood K","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.10.029"},{"key":"CIT0032","unstructured":"Institut National de la Statistique et des Etudes Economiques (INSEE). Indice des prix \u00e0 la consommation - Base 2015 - Ensemble des m\u00e9nages - France - Services de sant\u00e9. INSEE; 2018. [cited 2018 Aug]. Available from: https:\/\/www.insee.fr\/fr\/statistiques\/serie\/001763845"},{"key":"CIT0033","volume-title":"Rapport annuel du HCAAM","author":"Haut Conseil pour l\u2019avenir de l\u2019Assurance Maladie (HCAAM)","year":"2013"},{"key":"CIT0034","volume-title":"Comptes nationaux de la sant\u00e9 (CNS)","author":"Direction de la recherche des \u00e9tudes de l\u2019\u00e9valuation et des statistiques (DREES)","year":"2012"},{"key":"CIT0035","unstructured":"Caisse Nationale d\u2019Assurance Maladie (CNAM). Base des m\u00e9dicaments et informations tarifaires (BDM_IT); 2018. [cited 2018 Jul]. Available from: http:\/\/www.codage.ext.cnamts.fr\/codif\/bdm_it\/index.php?p_site=AMELI"},{"key":"CIT0036","unstructured":"Caisse Nationale d\u2019Assurance Maladie (CNAM). Classification commune des actes medicaux (CCAM) v54; 2018. [cited 2018 Jul]. Available from: https:\/\/www.ameli.fr\/accueil-de-la-ccam\/telechargement\/index.php"},{"key":"CIT0037","unstructured":"Caisse Nationale d\u2019Assurance Maladie (CNAM). Table nationale de codage de biologie (TNB); 2018. [cited 2018 Jul]. Available from: http:\/\/www.codage.ext.cnamts.fr\/codif\/nabm\/index_presentation.php?p_site=AMELI"},{"key":"CIT0038","unstructured":"Caisse Nationale d\u2019Assurance Maladie (CNAM). Liste des produits et des prestations (LPP); 2018. [cited 2018 Jul]. Available from: http:\/\/www.codage.ext.cnamts.fr\/codif\/tips\/index_presentation.php?p_site=AMELI"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166462"},{"key":"CIT0040","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation (ATIH). Tarifs MCO et HAD; 2018. [cited 2018 Jul]. Available from: https:\/\/www.atih.sante.fr\/tarifs-mco-et-had"},{"key":"CIT0041","unstructured":"ScanSant\u00e9. Activit\u00e9 MCO par GHM ou racine; 2017. [cited 2018 Jul]. Available from: https:\/\/www.scansante.fr\/applications\/statistiques-activite-MCO-par-GHM"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0112-1"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5090078"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1159\/000485933"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1159\/000496735"},{"key":"CIT0046","volume-title":"Nintedanib for treating idiopathic pulmonary fibrosis NICE","author":"NICE","year":"2015"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0480-2"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.3.218"}],"container-title":["Journal of Market Access & Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/20016689.2019.1626171","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20016689.2019.1626171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:02:51Z","timestamp":1705550571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/search?q=10.1080\/20016689.2019.1626171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"alternative-id":["10.1080\/20016689.2019.1626171"],"URL":"https:\/\/doi.org\/10.1080\/20016689.2019.1626171","relation":{},"ISSN":["2001-6689"],"issn-type":[{"value":"2001-6689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zjma20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zjma20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}